Tengfei Creation Center,55 Jiangjun Avenue, Jiangning District,Nanjing admin@sinochem-nanjing.com 3389378665@qq.com
Follow us:

L-Alanyl-L-Tyrosine

    • Product Name L-Alanyl-L-Tyrosine
    • Alias L-Alanyl-L-tyrosine
    • Einecs 257-392-7
    • Mininmum Order 1 g
    • Factory Site Tengfei Creation Center,55 Jiangjun Avenue, Jiangning District,Nanjing
    • Price Inquiry admin@sinochem-nanjing.com
    • Manufacturer Sinochem Nanjing Corporation
    • CONTACT NOW
    VTB
    Specifications

    HS Code

    494150

    Compound Name L-Alanyl-L-Tyrosine
    Chemical Formula C12H16N2O4
    Molecular Weight 252.27 g/mol
    Cas Number 3061-88-9
    Appearance White to off-white powder
    Solubility In Water Soluble
    Melting Point 233-238°C (dec.)
    Peptide Bond Dipeptide
    Optical Activity Chiral, optically active
    Storage Conditions Store at 2-8°C

    As an accredited L-Alanyl-L-Tyrosine factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.

    Packing & Storage
    Packing White, tightly sealed HDPE bottle containing 100 grams of L-Alanyl-L-Tyrosine, labeled with product details, hazard symbols, and batch information.
    Shipping L-Alanyl-L-Tyrosine is shipped in sealed, moisture-proof containers to maintain stability and prevent contamination. It is transported at controlled room temperature, away from direct sunlight and incompatible substances. Proper labeling, including hazard identification and handling instructions, ensures safe and compliant transit according to relevant chemical transport regulations.
    Storage L-Alanyl-L-Tyrosine should be stored in a tightly sealed container, protected from light and moisture. Store at 2-8°C (refrigerated) unless otherwise specified by the manufacturer. Keep away from incompatible substances, such as strong oxidizers, and avoid exposure to excessive heat. Proper storage ensures stability and prevents degradation or contamination of the compound.
    Application of L-Alanyl-L-Tyrosine

    Applications of L-Alanyl-L-Tyrosine in Industrial Manufacturing

    As a direct manufacturer of L-Alanyl-L-Tyrosine, we collaborate closely with industry stakeholders to ensure our ingredient meets demanding technical and regulatory requirements in several industrial sectors. The following sections outline the primary downstream use cases, detailing compliant standards, formulation ratios, integration into production processes, and end-product types as verified by actual customer adoption.

    1. Pharmaceutical Peptide Synthesis & Injectable Formulations

    Major pharmaceutical producers incorporate L-Alanyl-L-Tyrosine as a critical dipeptide building block for advanced peptide APIs and injectable drug products, especially where precise amino acid sequence control is essential. Its consistent purity supports complex synthetic routes and ensures batch-to-batch reproducibility for regulated injectable medicines, including those indicated for parenteral nutrition and specialized therapies.

    Industry compliance standards

    • USP-NF monographs (United States Pharmacopeia for excipients and peptides)
    • ICH Q7 Good Manufacturing Practice for Active Pharmaceutical Ingredients
    • European Pharmacopoeia (EP) requirements for amino acid derivatives
    • FDA cGMP 21 CFR Parts 210/211 for finished pharmaceuticals

    Typical usage ratio

    • Range: 0.2%–5% by weight in peptide formulation, adjusted according to API sequence design and molar equivalence
    • Dose calculated by number of dipeptide units in API structure

    Downstream process integration

    • Enters during solid-phase peptide synthesis (SPPS) as a protected dipeptide building block
    • Direct dissolution into sterile compounding for injectable solutions post-synthesis and purification

    Final product types

    • Sterile injectable peptides for clinical and hospital use
    • Custom therapeutic peptides for research and clinical trials
    • Specialty nutrition solutions for parenteral administration

    2. Functional Food and Nutraceuticals for Cognitive Support

    Leading dietary supplement manufacturers use L-Alanyl-L-Tyrosine in brain health and cognitive support formulations, capitalizing on its bioavailable dipeptide structure to enhance amino acid delivery. Used under controlled conditions, it supports finished products where rapid absorption and mental performance claims must align with international food ingredient rules and clean label standards.

    Industry compliance standards

    • Regulation (EU) No 1333/2008 on food additives
    • FDA GRAS evaluation (Generally Recognized as Safe) for amino acid-based supplements
    • China National Food Safety Standard GB 2760 for food additives
    • ISO 22000:2018 certification in supplement manufacturing

    Typical usage ratio

    • Range: 100 mg–500 mg per daily serving in finished product, depending on local regulatory limits and formulation goals
    • Adjusted for combination blends with other amino acids

    Downstream process integration

    • Powder mixing during premix blending for capsules or tablets
    • Direct addition to functional beverages and liquid shots during solution preparation

    Final product types

    • Cognitive health dietary supplements (capsules, tablets, powders)
    • Ready-to-drink functional beverages targeting mental focus
    • Sports and e-sports nutrition products emphasizing sustained concentration

    3. Clinical Nutrition & Medical Foods

    Manufacturers of clinical nutrition blends and medical foods incorporate L-Alanyl-L-Tyrosine in formulas intended for patients who require specialized protein or amino acid intake, such as those with metabolic disorders or recovering from surgery. This dipeptide form delivers both energy and bioactive tyrosine in nutrient-dense, readily absorbed enteral feeds formulated under strict medical production standards.

    Industry compliance standards

    • Codex Alimentarius CAC/GL 10-1979 guidelines for formula foods for special medical purposes
    • US FDA 21 CFR Part 105 for medical foods
    • EU Regulation No 609/2013 on food for specific groups (medical foods)
    • ISO 13485:2016 Medical Device Quality Management for liquid feeding systems

    Typical usage ratio

    • Added at 0.5–2.0 g per 100 g total protein in enteral formulas, fine-tuned per patient indication and nutritionist prescription

    Downstream process integration

    • Added to bulk blending tanks for powder or liquid meal replacement preparation
    • Sterilization or aseptic processing follows premix addition to preserve nutrient content and microbial safety

    Final product types

    • Enteral nutrition solutions for in-hospital use
    • Pediatric and geriatric clinical nutrition powders
    • Oral nutritional supplements in ready-to-drink bottles

    4. Cell Culture Media for Biomanufacturing

    Cell-based biomanufacturing facilities, including those producing recombinant proteins and monoclonal antibodies, use L-Alanyl-L-Tyrosine as a stable tyrosine donor in chemically defined cell culture media. This approach overcomes solubility issues typical of free tyrosine and enhances process scalability under tightly regulated manufacturing conditions for both human and veterinary biopharmaceuticals.

    Industry compliance standards

    • ICH Q5D Quality of Biotechnological Products: Derivation and Characterisation of Cell Substrates
    • USP Chapter <1043> Ancillary Materials for Cell, Gene, and Tissue-Engineered Products
    • ISO 9001:2015 for quality management in ancillary material production
    • FDA Guidance for Industry: Process Validation: General Principles and Practices (for bioprocesses)

    Typical usage ratio

    • 0.1–2 mmol/L in culture media, optimized for cell line requirements and specific protein expression profiles
    • Ratio adjusted based on tyrosine depletion rates during large-scale or perfusion culture

    Downstream process integration

    • Dissolution into base medium as a stable precursor before sterilization or filtration steps
    • Media supplementation for fed-batch and continuous perfusion fermenters

    Final product types

    • Recombinant therapeutic proteins for regulated markets
    • Monoclonal antibodies for clinical and diagnostic use
    • Viral vector and vaccine production intermediates
    Free Quote

    Competitive L-Alanyl-L-Tyrosine prices that fit your budget—flexible terms and customized quotes for every order.

    For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.

    We will respond to you as soon as possible.

    Tel: +8615371019725

    Email: admin@sinochem-nanjing.com

    Get Free Quote of Sinochem Nanjing Corporation

    Flexible payment, competitive price, premium service - Inquire now!

    Certification & Compliance
    More Introduction

    Introducing L-Alanyl-L-Tyrosine: The Manufacturer’s Perspective

    From the Production Floor: Understanding L-Alanyl-L-Tyrosine

    Stepping out of the lab and onto the factory floor, the development and production of L-Alanyl-L-Tyrosine marks a significant chapter in amino acid synthesis. We do not simply see this as another peptide or a routine addition to a product list. Peptide manufacturing requires years of investment in both equipment and expertise, and L-Alanyl-L-Tyrosine exemplifies why close attention to detail and process discipline matter so much in our industry.

    At every batch, our engineers measure the melting point, crystallinity, and water content, controlling for even minor deviations that can influence downstream processes. We weigh these factors in day-to-day QC monitoring since a product with inconsistent purity or unusual moisture can cause entire lots of finished goods to fail at later stages. This is not a theoretical risk. In the early years of manufacturing, a single wrong dryer setting resulted in a shipment with high endotoxin levels, teaching us with real consequences how tight those tolerances have to remain.

    The Backbone: L-Alanyl-L-Tyrosine’s Role and Specifications

    L-Alanyl-L-Tyrosine consists of two amino acids, L-Alanine and L-Tyrosine, joined through a peptide bond. In our process, we rely on fermentation-derived materials and chemical coupling, not animal sources. Over time, customers have started to demand routine verification for the absence of animal-derived DNA, so we have made PCR checks a standard part of quality assurance.

    Most customers request the powder form, typically presented as an off-white to white crystalline material. Granule size, bulk density, and residue testing form part of every lot release QC. Year over year, the feedback comes clear: excessive fine powder leads to caking in mixing hoppers, especially in humid conditions. We listened and made real investments in milling and sieving technology. A few microns off grain size often spell the difference between a smooth-run production batch and a compromised end product.

    On specifications, our L-Alanyl-L-Tyrosine achieves purity levels consistently above 98 percent (HPLC), with a residual solvent and heavy metal content far below regional regulatory thresholds. In practical terms, this means food and pharma manufacturers can integrate our material into their processes without unwanted variables. Tyrosine’s sensitivity to oxidation also means every drum is nitrogen-flushed and monitored for peroxide formation. This is not just compliance; small oversights can force expensive recalls, as operators know firsthand.

    Usage in Food, Beverages, and Pharmaceuticals

    L-Alanyl-L-Tyrosine is used by manufacturers looking to capitalize on the functional benefits of dipeptides—especially in nutritional and medical foods. Nutritional supplement brands often rely on peptide forms to enhance solubility and absorption compared to free L-Tyrosine. As food processors build products for aging or vulnerable populations, stability and bioavailability become central requirements. Here, L-Alanyl-L-Tyrosine holds up under typical heat and pH conditions encountered during manufacturing. Product developers working on instant beverages or parenteral nutrition mixes tell us that highly pure dipeptides dissolve faster and avoid many of the problems linked with badly formulated blends.

    Pharmaceutical applications call for even greater rigor. Over decades, we’ve partnered with formulation scientists coping with scale-up—demanding reliable batch-to-batch consistency and odor-neutral material. Peptides, including L-Alanyl-L-Tyrosine, must perform not just on the bench, but through tableting, granulation, and filling lines. Our technical team provides support beyond certificates, running pilot batches and sharing long-term stability data because minor deviations seen at the kilogram scale often result in major issues at the metric ton level.

    Customers in the biopharma sector ask for documentation on process validity, risk of cross-contamination, and traceability all the way back to the raw amino acids. In our experience, regulatory inspections focus as much on process transparency as on final product purity, so we maintain electronic batch records and preserve raw material retention samples for years after every lot ships.

    Differentiating from Standard Amino Acids

    Traditional single amino acids, including L-Tyrosine and L-Alanine, fill essential roles in both industry and human nutrition. Yet they do not always deliver the same outcomes as their peptide forms. Dipeptides like L-Alanyl-L-Tyrosine provide improved dissolution and absorption, especially in clinical nutrition and functional beverages. Years ago, beverage brands working with us tried direct use of L-Tyrosine, only to run into insolubility in cold water and sedimentation problems. Switching to the dipeptide resolved these issues, leading to clear drinks and better product shelf-life.

    The practical difference comes down to application readiness. Peptides bypass some of the sodium-dependent transporters needed for free amino acids. That translates to faster and sometimes more complete uptake in the gut, which matters for medical foods designed for malabsorption syndromes. Our trials with product formulators have repeatedly shown fewer issues with taste and bitterness, two complaints that often sink new launches in the supplement space.

    Manufacturing Challenges and Real-World Solutions

    Production lines rarely run as smoothly as flowcharts suggest. Generating L-Alanyl-L-Tyrosine involves precision coupling chemistry and robust purification protocols. In our early days, we ran several pilot batches where single-column purification did not remove enough by-products, triggering downstream contamination. The lesson turned into a decision to invest in double-column chromatography and more regular in-process controls—not because guidelines insist, but because operational headaches from failed filtration cost far more in the long run.

    Peptide production produces variable yields based on temperature control, reactant purity, and even minor environmental shifts. Routine temperature walks in the reactor area became part of daily practice, and data from those checks helps plan maintenance on heating and cooling systems before they break down mid-run. In one instance, a failed jacket thermometer sent a run out of spec, setting back two weeks of production time. That prompted us to overhaul monitoring procedures and add redundancy to our safety systems.

    Wastewater and solvent recovery creates another layer of operational challenge. We outfitted our site with on-site scrubbers and recovery units—not as a box-ticking exercise, but because out-of-date practices led to both regulatory sanctions and soaring disposal costs. Years later, our solvent recycle rates have improved, and our environmental compliance history backs up our commitment to sustainable manufacturing.

    Worker training closes the loop. Early mistakes taught us that even tiny lapses in cleaning between peptide batches can result in cross-contamination. Our technicians now adhere to strict cleaning validation, with regular audits. We put resources behind continued training, because process excellence depends on operator skill and attention as much as on hardware.

    Bridging R&D and Commercial Supply

    Developing L-Alanyl-L-Tyrosine at lab scale takes different expertise from scaling to commercial lots. In the past, we saw projects stalled by lack of communication between R&D and operations. Tablets pressed in the lab held together, but commercial batches caked or failed disintegration specs. As a result, our development team now runs scale-up trials in near-plant conditions before final process validation.

    We share findings with clients, particularly those working on new nutraceuticals or infusion solutions. Real samples and technical reports go out early in the process. Customers ask for protein mapping, impurity profiling, and allergen status, and expect honest answers—especially if process changes could impact downstream application. This dialogue has built both trust and better end products; clients who share stability data from their own accelerated aging trials help us improve production, too.

    Regulatory agencies in major markets scrutinize not just the peptide, but also every step in the making. Documentation—full lineage from raw material sourcing to batch release—must stand up to inspection. After one past audit, we implemented automated lot tracking and introduced a practice of keeping manufacturing chain-of-custody reports for at least five years. These practices exceed the minimum, but over time have lowered our risk exposure and improved customer confidence.

    Market Demands and Customer Feedback

    A few years ago, demand for functional peptides surged with the rise of high-protein beverages and meal replacements. Customers started requesting non-GMO, vegan, and allergen-free status for peptide products. We responded by securing third-party certifications and investing in dedicated processing lines for vegan and allergen-controlled production runs. It was a business decision rooted in customer feedback: one failed launch can put reputational risk on both the brand and the ingredient supplier.

    Supply chain stability cannot be taken for granted. The last major global disruption caused delays from both raw material suppliers and logistics providers. Our team responded by diversifying source partners and keeping a forward inventory buffer. Some partners ask for direct shipment in custom packaging and require specification flexibility to sync with their own production demands. We listen to these requests, balancing scale economies with tailored customer service, even if it means extra documentation and custom labeling.

    Comparing L-Alanyl-L-Tyrosine to Other Dipeptides

    In our facilities, L-Alanyl-L-Tyrosine shares many steps with the manufacturing of other dipeptides such as L-Alanyl-L-Glutamine or L-Tyrosylglycine. Each dipeptide has its own solubility, stability, and downstream handling issues. For example, L-Alanyl-L-Glutamine is prized for its role in clinical nutrition, but has higher moisture sensitivity and a greater tendency to hydrolyze during storage. L-Alanyl-L-Tyrosine resists hydrolysis better, and its crystalline form proves easier to process across tablet and powder applications.

    Differences in downstream usability often drive the choice for product formulators. Food technologists report L-Alanyl-L-Tyrosine as easier to blend into high-protein powders, supporting batch consistency in products with strict nutritional targets. The sensory properties of L-Alanyl-L-Tyrosine, such as reduced bitterness and neutral aroma, score favorably in many product application tests, giving it an advantage over free tyrosine and even some other dipeptides. We have seen this reflected in repeat customer orders, particularly from companies launching innovative sports nutrition, functional beverages, and enteral feeding formulas.

    Commitment to Long-Term Partnerships

    Our experience as manufacturers of L-Alanyl-L-Tyrosine underscores a simple point: product value grows out of attention to detail—at every step, from raw material procurement to finished delivery. Plant investments in advanced reactor technology, improved purification protocols, and staff training flow directly from the feedback loop we have with our customers.

    Open technical support and willingness to adapt have distinguished us from larger, slower-moving competition. We assist technical teams with troubleshooting blending, scaling, and analytical issues. Prototyping new formulations or helping solve solubility challenges is far more productive when both partners understand the unique behaviors of the dipeptide at every stage.

    Moving Forward: Meeting Evolving Industry Requirements

    Markets and technologies keep shifting. Specialty peptides, including L-Alanyl-L-Tyrosine, attract ongoing research from both medical and nutrition sectors. The move toward ‘clean label’ trends has increased requests for traceability documentation, GMO-free sourcing, and risk-free allergen statements. We continue to invest in quality control enhancements, rapid release testing, and third-party audits to support these requests.

    In our experience, thorough process validation, real-time analytics, and transparent supplier communications matter as much as the product itself. Ingredients such as L-Alanyl-L-Tyrosine only succeed when they match both strict technical standards and the real needs of industry partners. Every day, our teams walk the production floor, monitor control charts, and review feedback—not just to fill orders, but to help customers create the next generation of food and health products.